ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,993Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 120

$724K Total Retail Price of All Prescriptions

Rank: 15 out of 120

391 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 391 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

2% of this provider’s 6,256 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

40% of this provider’s prescriptions were for brand-name drugs, compared to an average of 49%.

Prescription Price

$91 was the average price of a prescription from this provider, compared to $124 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
METFORMIN HCL ER 312 234 1 6
AMLODIPINE BESYLATE 292 269 2 17
SIMVASTATIN 284 235 3 8
ATORVASTATIN CALCIUM 262 211 4 19
LEVOXYL 249 188 5 15
GLIMEPIRIDE 245 190 6 10
LISINOPRIL 245 213 6 14
METFORMIN HCL 235 181 8 3
LANTUS SOLOSTAR 213 137 9 5
SYNTHROID 210 149 10 1
PEN NEEDLE 183 103 11 4
LANTUS 181 147 12 7
HUMALOG 167 139 13 9
CRESTOR 160 124 14 20
LEVOTHYROXINE SODIUM 149 83 15 2
NOVOLOG FLEXPEN 143 82 16 11
GABAPENTIN 130 99 17 26
JANUVIA 116 94 18 18
FUROSEMIDE 115 99 19 21
ACTOS 112 101 20 24
OMEPRAZOLE 108 108 21 32
PRAVASTATIN SODIUM 107 95 22 22
LOSARTAN POTASSIUM 104 88 23 23
NOVOLOG 94 36 24 16
INSULIN SYRINGE 85 79 25 12
VICTOZA 2-PAK 78 54 26 68
DOXAZOSIN MESYLATE 73 73 27 135
CARVEDILOL 72 61 28 36
CALCITRIOL 71 68 29 75
GLIPIZIDE ER 71 64 29 41
METOPROLOL SUCCINATE 71 67 29 37
PIOGLITAZONE HCL 70 62 R 32 56
RAMIPRIL 65 47 33 60
BYETTA 54 25 34 30
CLONIDINE HCL 53 20 35 46
INDAPAMIDE 53 45 35 154
SPIRONOLACTONE 52 41 37 105
SERTRALINE HCL 51 43 38 71
GUANFACINE HCL 50 39 R 39 161
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 19, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.